In a filing, Olema Pharmaceuticals Inc revealed its Affiliate Logos Opportunities Fund I LP acquired Company’s shares for reported $4.73 million on Dec 13 ’24. In the deal valued at $6.75 per share,700,761 shares were bought.
Then, Harmon Cyrus sold 8,256 shares, generating $77,359 in total proceeds. Upon selling the shares at $9.37, the Director now owns 772,277 shares.
Before that, Harmon Cyrus sold 8,137 shares. Olema Pharmaceuticals Inc shares valued at $70,597 were divested by the Director at a price of $8.68 per share. As a result of the transaction, Harmon Cyrus now holds 764,140 shares, worth roughly $4.92 million.
Goldman initiated its Olema Pharmaceuticals Inc [OLMA] rating to a Buy in a research note published on April 02, 2024; the price target was $24. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. Oppenheimer began covering OLMA with “an Outperform” recommendation on July 21, 2023. CapitalOne started covering the stock on May 05, 2023. It rated OLMA as “an Overweight”.
Price Performance Review of OLMA
On Monday, Olema Pharmaceuticals Inc [NASDAQ:OLMA] saw its stock fall -4.59% to $6.44. Over the last five days, the stock has lost -31.78%. Olema Pharmaceuticals Inc shares have fallen nearly -54.10% since the year began. Nevertheless, the stocks have fallen -47.73% over the past one year. While a 52-week high of $16.77 was reached on 02/13/24, a 52-week low of $6.24 was recorded on 12/13/24. SMA at 50 days reached $10.63, while 200 days put it at $11.56.
Levels Of Support And Resistance For OLMA Stock
The 24-hour chart illustrates a support level at 6.17, which if violated will result in even more drops to 5.90. On the upside, there is a resistance level at 6.79. A further resistance level may holdings at 7.14. The Relative Strength Index (RSI) on the 14-day chart is 25.45, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.53, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.84%. Stochastics %K at 6.64% indicates the stock is a buying.
How much short interest is there in Olema Pharmaceuticals Inc?
A steep rise in short interest was recorded in Olema Pharmaceuticals Inc stocks on 2024-11-29, growing by 1.71 million shares to a total of 10.02 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 8.31 million shares. There was a rise of 17.03%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 22, 2023 when Credit Suisse began covering the stock and recommended ‘”an Outperform”‘ rating along with a $12 price target.
